WILMINGTON, MASSACHUSETTS -- (MARKET WIRE) -- March 07, 2007 -- DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA) announced today that the United States District Court in Newark, N.J. lifted the preliminary injunction against River’s Edge Pharmaceuticals LLC which had prevented it from selling its generic version of Nicomide®, a patented product of DUSA’s. The injunction had been in effect since May, 2006 following the filing of DUSA’s complaint alleging that River’s Edge’s product infringes DUSA’s patent. Nicomide® is one of the key products acquired by DUSA when it merged with Sirius Laboratories, Inc. in March of 2006.
